Company / Accounts Receivable
PLIANT THERAPEUTICS, INC. Accounts Receivable History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$2.0M
FY2022
5-year range
$2.0M / $2.0M
FY2020-FY2022
Trend
-0.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $9M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2022.
Declined from $9M to $2M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, accounts receivable decreased 0.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $2.0M | -0.8% |
| FY2021 | $2.0M | -78.5% |
| FY2020 | $9.3M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026